IPO Lockup Expiration Alert: Generation Bio (GBIO)

(RTTNews) - The lockup period of Generation Bio Co. (GBIO) ends on December 9, 2020.

Generation Bio is a pre-clinical stage genetic medicines company developing non-viral gene therapies for rare and prevalent diseases of the liver and retina.

The company is expected to select a development candidate for hemophilia A and phenylketonuria in 2021, with IND-enabling studies also expected to be initiated next year.

The company made its debut on The Nasdaq Global Select Market on June 12, 2020, offering its shares at a price of $19 each and the 180 day lockup period expires tomorrow.

GBIO opened the first day of trading (i.e. June 12, 2020) at $22.15 and closed at $24.69 that day. The stock has thus far hit a low of $17.00 and a high of $55.72.

GBIO closed Tuesday's trading at $48.85, up 1.26. But, in the after hours trading, the stock dropped 5.83% to $46.00.